Advanced Cancer: RO7759065 and Atezolizumab Study

We are investigating a new treatment combining RO7759065 with Atezolizumab for individuals with locally advanced or metastatic cancer. The goal is to understand how safe and effective this combination is for patients.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Bergonie
Medical Oncology
Bordeaux, France
Centre Leon Berard
Medical Oncology
Meyzieu, France
Institut Curie
Department of Drug Development and Innovation
Paris, France

Sponsor: Genentech Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.